For More Information
-
Stephen Paul Mahinka
Partner - Washington, D.C. -
Randall B. Sunberg
Partner - Princeton
Honors
LMG Life Sciences 2012 – Highly Recommended for Licensing and Collaboration, and for White Collar and Government Investigations. Recommended for FDA – Pharmaceuticals; Healthcare: Pricing and Reimbursement; Patent Prosecution; General Patent Litigation; Corporate; and Competition and Antitrust
PLCCross-border Quarterly 2012 Life Sciences Legal Market Review
- Life Sciences Regulatory Super League - Ranked 8th among law firms worldwide
PLCCross-border Life Sciences Handbook 2011/12
- U.S.:
- Commercial and Partnering - Highly Recommended
- Competition/Antitrust - Highly Recommended
- Corporate - Recommended
- Government Enforcement and Investigations - Highly Recommended
- Regulatory - Recommended
- Regulatory (Medical Devices) - Recommended
- England: Regulatory - Recommended
- Japan: Corporate and Commercial - Recommended
Chambers Global 2012: Global Life Sciences - Recommended - Band 3
Chambers USA 2012: National for Life Sciences - Band 3; Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory - Band 3
UK Legal 500 2010: London: Pharmaceuticals and Biotechnology
Best Lawyers in America 2011: Biotechnology and Healthcare Law Named
BioPharm Insight 2012
- Ranked 3rd - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Value
- Ranked 4th - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Volume
- Ranked 10th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Value
- Ranked 5th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Volume
- Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Value
- Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Volume
- Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Value
- Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Volume
U.S. News & World Report/Best Lawyers 2010: Ranked Tier 1 National Practice - Biotechnology
Clients
16 of the top 20 pharmaceutical companies
7 of the top 20 biotechnology companies
9 of the top 20 medical device companies
Industry Events
Related Events
Related News
Related Publications
- Overview
- Our People
- Selected Representations
- Publications of Interest
- Upcoming Events
- Related News
- << Back to Industries
- << Back to Practices
Areas of Experience
Life Sciences partner Stephen Paul Mahinka is quoted.
Jeffry S. Mann is listed as one of the "Top 25 Portfolio Managers/Patent Prosecutors" for 2013 by the Daily Journal.
Morgan Lewis served as legal adviser to MEI Pharma, Inc. on registered offering of common stock.
Life Sciences partner Stephen Paul Mahinka is quoted.
Life Sciences partner Stephen Paul Mahinka is quoted.
Morgan Lewis announces that Mark B. Stein has joined the firm in its Business and Finance Practice, resident in the firm's Boston office.
FDA & Healthcare partner Kathleen M. Sanzo is quoted.
Morgan Lewis partner Randall Sunberg is named one of Law360's Life Sciences MVPs.
FDA & Healthcare partner Katie McDermott is quoted.
Morgan Lewis's addition of a five-partner food, drug and medical device regulatory team to its Washington office is discussed.
Morgan Lewis announces that a team of five well-recognized FDA regulatory lawyers have joined the firm as partners in its FDA and Healthcare Practice, resident in Washington, D.C.
Life Sciences partner Stephen Paul Mahinka is quoted.
Life Sciences partner Stephen Paul Mahinka is quoted.
Life Sciences Partner Steve Mahinka is interviewed for Law360's Q&A series.
Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.
Business and Finance partner Randall Sunberg is interviewed as part of Law360's Q&A series.
Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.
Morgan Lewis served as legal advisor to GlaxoSmithKline on its investment in an Index Ventures fund solely dedicated to making investments in the life sciences sector.
Christopher Banks, Rollin Chippey II, and Benjamin Smith discuss their win in a recent pharmaceutical dispute.
Morgan Lewis today announces that Steven A. Reed has joined the firm as a partner in its Litigation Practice, resident in Philadelphia.
Morgan Lewis advised Perrigo Company, a global healthcare products supplier, on its acquisition of nearly all of the assets of Paddock Laboratories, Inc. for $540 million in cash.
In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.
BMP Sunstone and sanofi-aventis announced that they have entered into a definitive agreement where sanofi-aventis will acquire all outstanding shares of BMP Sunstone at $10 per share, or approximately $520.6 million.
Morgan Lewis placed highly among global law firms in BioPharm Insight’s second quarter licensing and mergers and acquisitions rankings.






